| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | MED12L MED15 MIDEAS SUPT20HL1 NCOR2 MAML3 NCOA6 EP300 NOTCH1 KMT2D SUPT20H | 7.93e-12 | 562 | 23 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MED12L MED15 MIDEAS SUPT20HL1 NCOR2 MAML3 NCOA6 EP300 NOTCH1 KMT2D SUPT20H | 1.72e-08 | 1160 | 23 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | MED12L MED15 MIDEAS SUPT20HL1 NCOR2 MAML3 NCOA6 EP300 NOTCH1 KMT2D SUPT20H | 8.59e-08 | 1356 | 23 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 9.44e-07 | 303 | 23 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.50e-06 | 20 | 23 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.52e-05 | 753 | 23 | 7 | GO:0008134 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 5.74e-05 | 187 | 23 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.48e-04 | 739 | 23 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.63e-04 | 21 | 23 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 3.16e-04 | 23 | 23 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | Notch binding | 4.38e-04 | 27 | 23 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 6.56e-04 | 33 | 23 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.21e-03 | 417 | 23 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.82e-03 | 55 | 23 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 4.07e-03 | 582 | 23 | 4 | GO:0140297 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 8.34e-03 | 120 | 23 | 2 | GO:0008013 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.12e-02 | 140 | 23 | 2 | GO:0001221 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MED12L MED15 NFAT5 SUPT20HL1 CCNK MAML3 NCOA6 EP300 ARID2 NOTCH1 KMT2D SUPT20H | 5.64e-09 | 1390 | 23 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryo development | FOXP2 SUPT20HL1 NCOR2 CCNK NCOA6 EP300 ARID2 NOTCH1 KMT2D SUPT20H | 1.29e-06 | 1437 | 23 | 10 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 2.49e-05 | 7 | 23 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 5.32e-05 | 10 | 23 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | DNA damage response | 5.85e-05 | 959 | 23 | 7 | GO:0006974 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 6.59e-05 | 71 | 23 | 3 | GO:0006111 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.21e-04 | 87 | 23 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | lung development | 2.06e-04 | 269 | 23 | 4 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 2.18e-04 | 273 | 23 | 4 | GO:0030323 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 2.48e-04 | 111 | 23 | 3 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 2.76e-04 | 115 | 23 | 3 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 3.20e-04 | 121 | 23 | 3 | GO:0046364 | |
| GeneOntologyBiologicalProcess | respiratory system development | 3.32e-04 | 305 | 23 | 4 | GO:0060541 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 3.75e-04 | 906 | 23 | 6 | GO:0043009 | |
| GeneOntologyBiologicalProcess | head development | 4.05e-04 | 919 | 23 | 6 | GO:0060322 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 4.13e-04 | 132 | 23 | 3 | GO:0043255 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 4.29e-04 | 929 | 23 | 6 | GO:0009792 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 4.32e-04 | 134 | 23 | 3 | GO:0010906 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 4.33e-04 | 596 | 23 | 5 | GO:0001701 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 4.51e-04 | 136 | 23 | 3 | GO:0030518 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 4.70e-04 | 138 | 23 | 3 | GO:0055017 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 5.42e-04 | 31 | 23 | 2 | GO:0060765 | |
| GeneOntologyBiologicalProcess | heart growth | 5.77e-04 | 148 | 23 | 3 | GO:0060419 | |
| GeneOntologyBiologicalProcess | positive regulation of gluconeogenesis | 5.78e-04 | 32 | 23 | 2 | GO:0045722 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 6.15e-04 | 33 | 23 | 2 | GO:2000737 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 6.53e-04 | 34 | 23 | 2 | GO:0090311 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA metabolic process | 6.53e-04 | 34 | 23 | 2 | GO:2000629 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 6.53e-04 | 34 | 23 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 6.60e-04 | 155 | 23 | 3 | GO:0043401 | |
| GeneOntologyBiologicalProcess | response to hormone | 7.88e-04 | 1042 | 23 | 6 | GO:0009725 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.06e-03 | 727 | 23 | 5 | GO:0032870 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | 1.25e-03 | 434 | 23 | 4 | GO:0062012 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 1.25e-03 | 47 | 23 | 2 | GO:0006476 | |
| GeneOntologyBiologicalProcess | heart development | 1.27e-03 | 757 | 23 | 5 | GO:0007507 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.42e-03 | 202 | 23 | 3 | GO:0141193 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 1.47e-03 | 51 | 23 | 2 | GO:0030521 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 1.64e-03 | 54 | 23 | 2 | GO:0032968 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle tissue growth | 1.77e-03 | 56 | 23 | 2 | GO:0055023 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 1.88e-03 | 223 | 23 | 3 | GO:0007519 | |
| GeneOntologyBiologicalProcess | viral transcription | 1.89e-03 | 58 | 23 | 2 | GO:0019083 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via JAK-STAT | 1.89e-03 | 58 | 23 | 2 | GO:0046427 | |
| GeneOntologyBiologicalProcess | protein deacylation | 1.89e-03 | 58 | 23 | 2 | GO:0035601 | |
| GeneOntologyBiologicalProcess | growth | 1.90e-03 | 1235 | 23 | 6 | GO:0040007 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 2.00e-03 | 228 | 23 | 3 | GO:0001101 | |
| GeneOntologyBiologicalProcess | positive regulation of heart growth | 2.02e-03 | 60 | 23 | 2 | GO:0060421 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 2.08e-03 | 231 | 23 | 3 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 2.08e-03 | 231 | 23 | 3 | GO:0006109 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 2.09e-03 | 61 | 23 | 2 | GO:0060428 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 2.16e-03 | 234 | 23 | 3 | GO:0006282 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 2.16e-03 | 62 | 23 | 2 | GO:0032786 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.18e-03 | 1269 | 23 | 6 | GO:0009887 | |
| GeneOntologyBiologicalProcess | brain development | 2.23e-03 | 859 | 23 | 5 | GO:0007420 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 2.23e-03 | 63 | 23 | 2 | GO:0098732 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.29e-03 | 239 | 23 | 3 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of glucose metabolic process | 2.30e-03 | 64 | 23 | 2 | GO:0010907 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 2.30e-03 | 64 | 23 | 2 | GO:0072538 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 2.32e-03 | 240 | 23 | 3 | GO:0060538 | |
| GeneOntologyBiologicalProcess | regulation of collagen biosynthetic process | 2.37e-03 | 65 | 23 | 2 | GO:0032965 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via STAT | 2.37e-03 | 65 | 23 | 2 | GO:1904894 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 2.43e-03 | 244 | 23 | 3 | GO:0006006 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 2.43e-03 | 244 | 23 | 3 | GO:0009755 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.74e-06 | 596 | 22 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 4.82e-05 | 1377 | 22 | 8 | GO:0140513 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 6.93e-05 | 12 | 22 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.27e-04 | 94 | 22 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.72e-04 | 104 | 22 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.98e-04 | 109 | 22 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | SAGA complex | 3.13e-04 | 25 | 22 | 2 | GO:0000124 | |
| GeneOntologyCellularComponent | transferase complex | 3.72e-04 | 963 | 22 | 6 | GO:1990234 | |
| GeneOntologyCellularComponent | chromatin | 5.82e-04 | 1480 | 22 | 7 | GO:0000785 | |
| GeneOntologyCellularComponent | SAGA-type complex | 7.65e-04 | 39 | 22 | 2 | GO:0070461 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.80e-03 | 75 | 22 | 2 | GO:0035097 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.58e-03 | 85 | 22 | 2 | GO:0000118 | |
| GeneOntologyCellularComponent | methyltransferase complex | 5.71e-03 | 108 | 22 | 2 | GO:0034708 | |
| GeneOntologyCellularComponent | peptidase complex | 8.54e-03 | 133 | 22 | 2 | GO:1905368 | |
| GeneOntologyCellularComponent | nuclear matrix | 9.42e-03 | 140 | 22 | 2 | GO:0016363 | |
| HumanPheno | Thin vermilion border | 9.90e-08 | 433 | 10 | 8 | HP:0000233 | |
| HumanPheno | Thin upper lip vermilion | 5.49e-07 | 339 | 10 | 7 | HP:0000219 | |
| HumanPheno | Thin lips | 5.49e-07 | 339 | 10 | 7 | HP:0000213 | |
| HumanPheno | Prominent fingertip pads | 1.18e-06 | 46 | 10 | 4 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 1.40e-06 | 48 | 10 | 4 | HP:0011298 | |
| HumanPheno | Autistic behavior | 3.33e-06 | 678 | 10 | 8 | HP:0000729 | |
| HumanPheno | Abnormality of upper lip vermillion | 4.69e-06 | 464 | 10 | 7 | HP:0011339 | |
| HumanPheno | High, narrow palate | 5.63e-06 | 156 | 10 | 5 | HP:0002705 | |
| HumanPheno | Diagnostic behavioral phenotype | 7.07e-06 | 747 | 10 | 8 | HP:0025783 | |
| HumanPheno | Low-set ears | 8.16e-06 | 761 | 10 | 8 | HP:0000369 | |
| HumanPheno | Delayed speech and language development | 9.63e-06 | 1123 | 10 | 9 | HP:0000750 | |
| HumanPheno | Language impairment | 1.47e-05 | 1178 | 10 | 9 | HP:0002463 | |
| HumanPheno | Short columella | 1.94e-05 | 29 | 10 | 3 | HP:0002000 | |
| HumanPheno | Clinodactyly | 1.97e-05 | 574 | 10 | 7 | HP:0030084 | |
| HumanPheno | Narrow palate | 2.00e-05 | 202 | 10 | 5 | HP:0000189 | |
| HumanPheno | Abnormality of globe location or size | 2.40e-05 | 1246 | 10 | 9 | HP:0000489 | |
| HumanPheno | Abnormal lip morphology | 2.45e-05 | 1249 | 10 | 9 | HP:0000159 | |
| HumanPheno | Abnormality of the palpebral fissures | 2.50e-05 | 880 | 10 | 8 | HP:0008050 | |
| HumanPheno | Abnormal nasal tip morphology | 2.94e-05 | 386 | 10 | 6 | HP:0000436 | |
| HumanPheno | Abnormal external nose morphology | 3.40e-05 | 916 | 10 | 8 | HP:0010938 | |
| HumanPheno | Prominent nose | 3.91e-05 | 110 | 10 | 4 | HP:0000448 | |
| HumanPheno | Abnormal location of ears | 4.31e-05 | 945 | 10 | 8 | HP:0000357 | |
| HumanPheno | Abnormal lower lip morphology | 4.81e-05 | 242 | 10 | 5 | HP:0000178 | |
| HumanPheno | Abnormality of mouth size | 5.12e-05 | 425 | 10 | 6 | HP:0011337 | |
| HumanPheno | Abnormal upper lip morphology | 5.69e-05 | 980 | 10 | 8 | HP:0000177 | |
| HumanPheno | Abnormal eyebrow morphology | 5.76e-05 | 674 | 10 | 7 | HP:0000534 | |
| HumanPheno | Abnormal finger morphology | 6.03e-05 | 1385 | 10 | 9 | HP:0001167 | |
| HumanPheno | Postnatal growth retardation | 6.55e-05 | 258 | 10 | 5 | HP:0008897 | |
| HumanPheno | Abnormal eyelid morphology | 6.95e-05 | 1408 | 10 | 9 | HP:0000492 | |
| HumanPheno | Finger clinodactyly | 7.28e-05 | 452 | 10 | 6 | HP:0040019 | |
| HumanPheno | Motor delay | 7.60e-05 | 1018 | 10 | 8 | HP:0001270 | |
| HumanPheno | Abnormality of the philtrum | 9.42e-05 | 726 | 10 | 7 | HP:0000288 | |
| HumanPheno | Hypoplastic left heart | 9.58e-05 | 49 | 10 | 3 | HP:0004383 | |
| HumanPheno | Congenital malformation of the left heart | 1.08e-04 | 51 | 10 | 3 | HP:0045017 | |
| HumanPheno | Abnormal hand morphology | 1.21e-04 | 1082 | 10 | 8 | HP:0005922 | |
| HumanPheno | Abnormality of the hairline | 1.23e-04 | 294 | 10 | 5 | HP:0009553 | |
| HumanPheno | Pilomatrixoma | 1.24e-04 | 9 | 10 | 2 | HP:0030434 | |
| HumanPheno | Hypoplastic heart | 1.28e-04 | 54 | 10 | 3 | HP:0001961 | |
| HumanPheno | Abnormal size of the palpebral fissures | 1.31e-04 | 298 | 10 | 5 | HP:0200007 | |
| HumanPheno | Abnormal 5th finger morphology | 1.43e-04 | 509 | 10 | 6 | HP:0004207 | |
| HumanPheno | Gastroesophageal reflux | 1.56e-04 | 517 | 10 | 6 | HP:0002020 | |
| HumanPheno | Abnormality of globe location | 1.59e-04 | 1122 | 10 | 8 | HP:0100886 | |
| HumanPheno | Abnormality of calvarial morphology | 1.72e-04 | 1134 | 10 | 8 | HP:0002648 | |
| HumanPheno | Congenital malformation of the great arteries | 1.78e-04 | 529 | 10 | 6 | HP:0011603 | |
| HumanPheno | Deviation of finger | 1.93e-04 | 537 | 10 | 6 | HP:0004097 | |
| HumanPheno | Short finger | 1.98e-04 | 325 | 10 | 5 | HP:0009381 | |
| HumanPheno | Congenital abnormal hair pattern | 2.04e-04 | 327 | 10 | 5 | HP:0011361 | |
| HumanPheno | Feeding difficulties | 2.15e-04 | 1168 | 10 | 8 | HP:0011968 | |
| HumanPheno | Hypertelorism | 2.27e-04 | 830 | 10 | 7 | HP:0000316 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | 2.55e-04 | 564 | 10 | 6 | HP:0009484 | |
| HumanPheno | Cupped ear | 2.67e-04 | 69 | 10 | 3 | HP:0000378 | |
| HumanPheno | Downturned corners of mouth | 2.80e-04 | 182 | 10 | 4 | HP:0002714 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 3.47e-04 | 366 | 10 | 5 | HP:0006265 | |
| HumanPheno | Abnormal calvaria morphology | 3.65e-04 | 1254 | 10 | 8 | HP:0002683 | |
| HumanPheno | Bulbous nose | 4.10e-04 | 201 | 10 | 4 | HP:0000414 | |
| HumanPheno | Abnormal fingertip morphology | 4.26e-04 | 203 | 10 | 4 | HP:0001211 | |
| HumanPheno | Premature thelarche | 4.64e-04 | 17 | 10 | 2 | HP:0010314 | |
| HumanPheno | Prominent eyelashes | 4.64e-04 | 17 | 10 | 2 | HP:0011231 | |
| HumanPheno | Abnormal pinna morphology | 4.75e-04 | 1299 | 10 | 8 | HP:0000377 | |
| HumanPheno | Skin appendage neoplasm | 5.22e-04 | 18 | 10 | 2 | HP:0012842 | |
| HumanPheno | Hirsutism | 5.40e-04 | 216 | 10 | 4 | HP:0001007 | |
| HumanPheno | Aplasia/Hypoplasia of the ear | 5.69e-04 | 219 | 10 | 4 | HP:0008771 | |
| HumanPheno | Macrostomia | 5.79e-04 | 220 | 10 | 4 | HP:0000181 | |
| HumanPheno | Wide mouth | 5.79e-04 | 220 | 10 | 4 | HP:0000154 | |
| HumanPheno | Recurrent ear infections | 5.83e-04 | 19 | 10 | 2 | HP:0410018 | |
| HumanPheno | Abnormality of the outer ear | 5.89e-04 | 1337 | 10 | 8 | HP:0000356 | |
| HumanPheno | Clinodactyly of the 5th finger | 6.62e-04 | 420 | 10 | 5 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 6.69e-04 | 421 | 10 | 5 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 6.69e-04 | 421 | 10 | 5 | HP:0009179 | |
| HumanPheno | Delayed early-childhood social milestone development | 7.14e-04 | 21 | 10 | 2 | HP:0012434 | |
| HumanPheno | Abnormal columella morphology | 7.29e-04 | 97 | 10 | 3 | HP:0009929 | |
| HumanPheno | Brachydactyly (hand) | 7.38e-04 | 430 | 10 | 5 | HP:0100667 | |
| HumanPheno | Abnormality of the scalp hair | 7.62e-04 | 433 | 10 | 5 | HP:0100037 | |
| HumanPheno | Radial deviation of finger | 8.93e-04 | 448 | 10 | 5 | HP:0009466 | |
| HumanPheno | Abnormal scalp morphology | 9.12e-04 | 450 | 10 | 5 | HP:0001965 | |
| HumanPheno | Abnormal hair morphology | 9.38e-04 | 1424 | 10 | 8 | HP:0001595 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 9.69e-04 | 456 | 10 | 5 | HP:0009485 | |
| HumanPheno | Abnormal aortic arch morphology | 1.03e-03 | 109 | 10 | 3 | HP:0012303 | |
| HumanPheno | Complex cardiac malformations | 1.04e-03 | 257 | 10 | 4 | HP:0002565 | |
| HumanPheno | Large forehead | 1.10e-03 | 26 | 10 | 2 | HP:0002003 | |
| HumanPheno | Abnormal semicircular canal morphology | 1.10e-03 | 26 | 10 | 2 | HP:0011380 | |
| HumanPheno | Abnormal morphology of the great vessels | 1.11e-03 | 736 | 10 | 6 | HP:0030962 | |
| HumanPheno | Posteriorly rotated ears | 1.11e-03 | 470 | 10 | 5 | HP:0000358 | |
| HumanPheno | Abnormal nasal dorsum morphology | 1.12e-03 | 262 | 10 | 4 | HP:0011119 | |
| HumanPheno | Frontal bossing | 1.13e-03 | 738 | 10 | 6 | HP:0002007 | |
| HumanPheno | Slanting of the palpebral fissure | 1.14e-03 | 739 | 10 | 6 | HP:0200006 | |
| HumanPheno | Aortic valve stenosis | 1.14e-03 | 113 | 10 | 3 | HP:0001650 | |
| HumanPheno | Abnormal shape of the frontal region | 1.16e-03 | 741 | 10 | 6 | HP:0011218 | |
| HumanPheno | Abnormal frontal bone morphology | 1.16e-03 | 742 | 10 | 6 | HP:0430000 | |
| HumanPheno | Abnormal stomach morphology | 1.16e-03 | 742 | 10 | 6 | HP:0002577 | |
| HumanPheno | Abnormal nasal septum morphology | 1.20e-03 | 115 | 10 | 3 | HP:0000419 | |
| HumanPheno | Abnormal esophagus morphology | 1.22e-03 | 1078 | 10 | 7 | HP:0002031 | |
| HumanPheno | Low posterior hairline | 1.26e-03 | 117 | 10 | 3 | HP:0002162 | |
| HumanPheno | Abnormality of the posterior hairline | 1.26e-03 | 117 | 10 | 3 | HP:0030141 | |
| HumanPheno | Mitral stenosis | 1.28e-03 | 28 | 10 | 2 | HP:0001718 | |
| HumanPheno | Bicuspid aortic valve | 1.32e-03 | 119 | 10 | 3 | HP:0001647 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 1.39e-03 | 121 | 10 | 3 | HP:0031567 | |
| HumanPheno | Downslanted palpebral fissures | 1.44e-03 | 497 | 10 | 5 | HP:0000494 | |
| HumanPheno | Abnormal ventriculoarterial connection | 1.44e-03 | 280 | 10 | 4 | HP:0011563 | |
| HumanPheno | Motor stereotypy | 1.44e-03 | 280 | 10 | 4 | HP:0000733 | |
| MousePheno | abnormal myocardium compact layer morphology | 4.17e-08 | 67 | 21 | 5 | MP:0004056 | |
| MousePheno | abnormal left-right axis symmetry of the somites | 1.63e-07 | 8 | 21 | 3 | MP:0005224 | |
| MousePheno | heart hypoplasia | 1.51e-05 | 103 | 21 | 4 | MP:0002740 | |
| MousePheno | abnormal vitelline vasculature morphology | 2.10e-05 | 235 | 21 | 5 | MP:0003229 | |
| MousePheno | abnormal myocardium layer morphology | 2.42e-05 | 414 | 21 | 6 | MP:0005329 | |
| MousePheno | abnormal heart layer morphology | 2.70e-05 | 422 | 21 | 6 | MP:0010545 | |
| MousePheno | incomplete somite formation | 3.72e-05 | 44 | 21 | 3 | MP:0001689 | |
| MousePheno | thin myocardium compact layer | 4.25e-05 | 46 | 21 | 3 | MP:0004057 | |
| MousePheno | thin ventricular wall | 4.78e-05 | 138 | 21 | 4 | MP:0000280 | |
| MousePheno | abnormal fetal cardiomyocyte proliferation | 4.84e-05 | 48 | 21 | 3 | MP:0003567 | |
| MousePheno | abnormal myocardial trabeculae morphology | 5.64e-05 | 144 | 21 | 4 | MP:0002189 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 6.16e-05 | 489 | 21 | 6 | MP:0010630 | |
| MousePheno | abnormal fetal cardiomyocyte physiology | 7.29e-05 | 55 | 21 | 3 | MP:0011390 | |
| MousePheno | craniofacial phenotype | 8.10e-05 | 1372 | 21 | 9 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 8.10e-05 | 1372 | 21 | 9 | MP:0000428 | |
| MousePheno | abnormal gastrulation movements | 9.60e-05 | 10 | 21 | 2 | MP:0002174 | |
| MousePheno | abnormal heart ventricle morphology | 1.06e-04 | 793 | 21 | 7 | MP:0005294 | |
| MousePheno | abnormal vascular development | 1.09e-04 | 542 | 21 | 6 | MP:0000259 | |
| MousePheno | abnormal cardiovascular development | 1.14e-04 | 802 | 21 | 7 | MP:0002925 | |
| MousePheno | abnormal left-right axis patterning | 1.32e-04 | 67 | 21 | 3 | MP:0001706 | |
| MousePheno | ventricle myocardium hypoplasia | 1.56e-04 | 71 | 21 | 3 | MP:0010502 | |
| MousePheno | prenatal growth retardation | 1.88e-04 | 869 | 21 | 7 | MP:0010865 | |
| MousePheno | abnormal trabecula carnea morphology | 2.07e-04 | 78 | 21 | 3 | MP:0004067 | |
| MousePheno | myocardium hypoplasia | 2.76e-04 | 86 | 21 | 3 | MP:0010500 | |
| MousePheno | abnormal epicardium morphology | 2.88e-04 | 17 | 21 | 2 | MP:0003057 | |
| MousePheno | abnormal somite development | 3.00e-04 | 222 | 21 | 4 | MP:0001688 | |
| MousePheno | abnormal pericardium morphology | 3.15e-04 | 225 | 21 | 4 | MP:0000288 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 3.24e-04 | 18 | 21 | 2 | MP:0011395 | |
| MousePheno | abnormal heart ventricle wall thickness | 3.26e-04 | 227 | 21 | 4 | MP:0020135 | |
| MousePheno | abnormal hippocampus layer morphology | 3.37e-04 | 92 | 21 | 3 | MP:0000813 | |
| MousePheno | lethality throughout fetal growth and development | 3.84e-04 | 435 | 21 | 5 | MP:0006208 | |
| MousePheno | ventricular hypoplasia | 4.18e-04 | 99 | 21 | 3 | MP:0000279 | |
| MousePheno | impaired somite development | 4.83e-04 | 104 | 21 | 3 | MP:0009768 | |
| MousePheno | ventricular septal defect | 5.53e-04 | 261 | 21 | 4 | MP:0010402 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 5.69e-04 | 263 | 21 | 4 | MP:0011099 | |
| MousePheno | abnormal ventricle myocardium morphology | 6.64e-04 | 116 | 21 | 3 | MP:0010499 | |
| MousePheno | abnormal forebrain morphology | 6.83e-04 | 1072 | 21 | 7 | MP:0000783 | |
| MousePheno | embryonic growth retardation | 6.94e-04 | 763 | 21 | 6 | MP:0003984 | |
| MousePheno | abnormal heart ventricle wall morphology | 8.87e-04 | 296 | 21 | 4 | MP:0031532 | |
| MousePheno | abnormal telencephalon morphology | 9.63e-04 | 812 | 21 | 6 | MP:0000787 | |
| MousePheno | abnormal rostral-caudal axis patterning | 9.66e-04 | 132 | 21 | 3 | MP:0005221 | |
| MousePheno | small heart | 1.20e-03 | 321 | 21 | 4 | MP:0002188 | |
| MousePheno | abnormal interventricular septum morphology | 1.52e-03 | 342 | 21 | 4 | MP:0000281 | |
| MousePheno | abnormal paraxial mesoderm morphology | 1.62e-03 | 40 | 21 | 2 | MP:0008029 | |
| MousePheno | embryo tissue necrosis | 1.62e-03 | 40 | 21 | 2 | MP:0013241 | |
| MousePheno | disorganized myocardium | 1.62e-03 | 40 | 21 | 2 | MP:0002190 | |
| MousePheno | abnormal placenta development | 1.68e-03 | 160 | 21 | 3 | MP:0001712 | |
| MousePheno | abnormal extraembryonic tissue morphology | 1.72e-03 | 908 | 21 | 6 | MP:0002086 | |
| MousePheno | abnormal nervous system development | 1.76e-03 | 1257 | 21 | 7 | MP:0003861 | |
| MousePheno | abnormal heart valve morphology | 1.77e-03 | 163 | 21 | 3 | MP:0000285 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.86e-03 | 1269 | 21 | 7 | MP:0011111 | |
| MousePheno | increased megakaryocyte cell number | 2.05e-03 | 45 | 21 | 2 | MP:0008254 | |
| MousePheno | abnormal heart development | 2.06e-03 | 372 | 21 | 4 | MP:0000267 | |
| MousePheno | trabecula carnea hypoplasia | 2.14e-03 | 46 | 21 | 2 | MP:0000295 | |
| MousePheno | abnormal limbic system morphology | 2.19e-03 | 378 | 21 | 4 | MP:0004166 | |
| MousePheno | abnormal bile salt homeostasis | 2.23e-03 | 47 | 21 | 2 | MP:0005365 | |
| MousePheno | abnormal eye pigmentation | 2.32e-03 | 179 | 21 | 3 | MP:0001324 | |
| MousePheno | abnormal heart septum morphology | 2.40e-03 | 388 | 21 | 4 | MP:0006113 | |
| MousePheno | abnormal extracutaneous pigmentation | 2.58e-03 | 186 | 21 | 3 | MP:0009389 | |
| MousePheno | increased insulin sensitivity | 2.66e-03 | 188 | 21 | 3 | MP:0002891 | |
| MousePheno | abnormal placenta vasculature | 2.83e-03 | 192 | 21 | 3 | MP:0003231 | |
| MousePheno | caudal body truncation | 2.93e-03 | 54 | 21 | 2 | MP:0004073 | |
| MousePheno | abnormal vasculogenesis | 2.93e-03 | 54 | 21 | 2 | MP:0001622 | |
| MousePheno | failure of initiation of embryo turning | 3.15e-03 | 56 | 21 | 2 | MP:0004180 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 3.23e-03 | 700 | 21 | 5 | MP:0011098 | |
| MousePheno | abnormal hippocampus pyramidal cell morphology | 3.26e-03 | 57 | 21 | 2 | MP:0009940 | |
| MousePheno | kinked neural tube | 3.26e-03 | 57 | 21 | 2 | MP:0003400 | |
| MousePheno | abnormal placenta physiology | 3.36e-03 | 204 | 21 | 3 | MP:0010038 | |
| MousePheno | myocardial trabeculae hypoplasia | 3.38e-03 | 58 | 21 | 2 | MP:0010503 | |
| Domain | SANT_dom | 4.23e-04 | 26 | 22 | 2 | IPR017884 | |
| Domain | SANT | 4.91e-04 | 28 | 22 | 2 | PS51293 | |
| Domain | Myb_DNA-binding | 7.70e-04 | 35 | 22 | 2 | PF00249 | |
| Domain | MYB_LIKE | 9.08e-04 | 38 | 22 | 2 | PS50090 | |
| Domain | SANT | 1.57e-03 | 50 | 22 | 2 | SM00717 | |
| Domain | SANT/Myb | 1.69e-03 | 52 | 22 | 2 | IPR001005 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.43e-07 | 10 | 16 | 3 | MM15535 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.92e-07 | 47 | 16 | 4 | M7946 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.09e-07 | 48 | 16 | 4 | M611 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 4.33e-07 | 14 | 16 | 3 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 4.52e-07 | 58 | 16 | 4 | M29616 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 5.55e-07 | 61 | 16 | 4 | M39540 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 6.66e-07 | 16 | 16 | 3 | M27121 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 7.19e-07 | 65 | 16 | 4 | M39682 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 9.69e-07 | 18 | 16 | 3 | MM14775 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.21e-06 | 74 | 16 | 4 | M616 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.35e-06 | 20 | 16 | 3 | M27881 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.84e-06 | 82 | 16 | 4 | MM15922 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.02e-06 | 84 | 16 | 4 | M1008 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.10e-06 | 23 | 16 | 3 | MM14954 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.72e-06 | 25 | 16 | 3 | M27880 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.86e-06 | 28 | 16 | 3 | M6177 | |
| Pathway | REACTOME_ADIPOGENESIS | 5.94e-06 | 110 | 16 | 4 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 7.86e-06 | 118 | 16 | 4 | M27316 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 9.46e-06 | 272 | 16 | 5 | M29619 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.07e-05 | 39 | 16 | 3 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.34e-05 | 42 | 16 | 3 | M17541 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.65e-05 | 45 | 16 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.77e-05 | 46 | 16 | 3 | MM15971 | |
| Pathway | PID_HES_HEY_PATHWAY | 2.01e-05 | 48 | 16 | 3 | M288 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.14e-05 | 49 | 16 | 3 | M618 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 2.42e-05 | 51 | 16 | 3 | M665 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.37e-05 | 8 | 16 | 2 | M48024 | |
| Pathway | PID_NOTCH_PATHWAY | 3.75e-05 | 59 | 16 | 3 | M17 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 5.37e-05 | 1387 | 16 | 8 | M734 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 6.00e-05 | 69 | 16 | 3 | M46439 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.60e-05 | 11 | 16 | 2 | M48021 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 7.57e-05 | 210 | 16 | 4 | M41836 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.92e-05 | 12 | 16 | 2 | M27159 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 7.92e-05 | 12 | 16 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 7.92e-05 | 12 | 16 | 2 | M47533 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 8.02e-05 | 76 | 16 | 3 | MM15520 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 9.35e-05 | 13 | 16 | 2 | M47534 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 9.35e-05 | 13 | 16 | 2 | MM15622 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.01e-04 | 82 | 16 | 3 | M594 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.28e-04 | 768 | 16 | 6 | MM14851 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.40e-04 | 246 | 16 | 4 | M10189 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.51e-04 | 94 | 16 | 3 | M1041 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.61e-04 | 96 | 16 | 3 | M27784 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.83e-04 | 18 | 16 | 2 | M26942 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.03e-04 | 119 | 16 | 3 | M607 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 3.26e-04 | 122 | 16 | 3 | M29689 | |
| Pathway | REACTOME_GASTRULATION | 3.84e-04 | 129 | 16 | 3 | M46433 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 3.86e-04 | 26 | 16 | 2 | M2499 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.86e-04 | 26 | 16 | 2 | MM14793 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 4.17e-04 | 27 | 16 | 2 | M39545 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.82e-04 | 29 | 16 | 2 | M48076 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 5.16e-04 | 30 | 16 | 2 | M207 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.50e-04 | 1432 | 16 | 7 | M509 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 6.08e-04 | 1022 | 16 | 6 | MM15436 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 6.25e-04 | 33 | 16 | 2 | M604 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 7.34e-04 | 161 | 16 | 3 | M27871 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 7.44e-04 | 36 | 16 | 2 | M633 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 7.86e-04 | 37 | 16 | 2 | M27797 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 7.86e-04 | 37 | 16 | 2 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 9.65e-04 | 41 | 16 | 2 | MM14876 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.01e-03 | 42 | 16 | 2 | M48018 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.11e-03 | 44 | 16 | 2 | M27295 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.11e-03 | 44 | 16 | 2 | MM15527 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586 | 1.21e-03 | 46 | 16 | 2 | M39661 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.27e-03 | 47 | 16 | 2 | M29777 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.38e-03 | 49 | 16 | 2 | M41832 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 1.54e-03 | 464 | 16 | 4 | M27547 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.55e-03 | 52 | 16 | 2 | M2404 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 2.06e-03 | 60 | 16 | 2 | M41830 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.23e-03 | 237 | 16 | 3 | M27786 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 2.27e-03 | 63 | 16 | 2 | M27862 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 2.34e-03 | 64 | 16 | 2 | M200 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 2.48e-03 | 66 | 16 | 2 | M101 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.72e-03 | 254 | 16 | 3 | M27131 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 2.79e-03 | 70 | 16 | 2 | M938 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.36e-03 | 77 | 16 | 2 | MM14670 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 3.80e-03 | 82 | 16 | 2 | M2 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 4.39e-03 | 301 | 16 | 3 | MM15983 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.66e-03 | 91 | 16 | 2 | M27101 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 4.66e-03 | 91 | 16 | 2 | M39700 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2 | 5.18e-03 | 96 | 16 | 2 | M45026 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 5.18e-03 | 96 | 16 | 2 | M27792 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 5.39e-03 | 98 | 16 | 2 | M48247 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 7.72e-03 | 118 | 16 | 2 | MM15588 | |
| Pubmed | 2.65e-12 | 23 | 23 | 5 | 9225980 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 7.50e-12 | 457 | 23 | 9 | 32344865 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.27e-11 | 351 | 23 | 8 | 38297188 | |
| Pubmed | 2.23e-09 | 83 | 23 | 5 | 28794006 | ||
| Pubmed | MED15 FOXP2 MIDEAS HELZ NCOR2 NCOA6 EP300 ARID2 KMT2D SUPT20H | 9.32e-09 | 1429 | 23 | 10 | 35140242 | |
| Pubmed | 1.72e-08 | 1103 | 23 | 9 | 34189442 | ||
| Pubmed | 4.63e-08 | 549 | 23 | 7 | 38280479 | ||
| Pubmed | 4.71e-08 | 152 | 23 | 5 | 38360978 | ||
| Pubmed | 1.28e-07 | 638 | 23 | 7 | 31182584 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.85e-07 | 398 | 23 | 6 | 35016035 | |
| Pubmed | 2.86e-07 | 20 | 23 | 3 | 11877444 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.97e-07 | 220 | 23 | 5 | 35785414 | |
| Pubmed | 3.33e-07 | 21 | 23 | 3 | 19596656 | ||
| Pubmed | 5.96e-07 | 486 | 23 | 6 | 20936779 | ||
| Pubmed | 7.86e-07 | 268 | 23 | 5 | 33640491 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 27566587 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 37410700 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 24220028 | ||
| Pubmed | p300 acts as a transcriptional coactivator for mammalian Notch-1. | 1.25e-06 | 3 | 23 | 2 | 11604511 | |
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 28732206 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 28398509 | ||
| Pubmed | Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR). | 2.51e-06 | 4 | 23 | 2 | 17073437 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 12754253 | ||
| Pubmed | Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein. | 2.51e-06 | 4 | 23 | 2 | 22888005 | |
| Pubmed | LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding. | 2.51e-06 | 4 | 23 | 2 | 27118681 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 10713164 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 12391150 | ||
| Pubmed | Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1. | 2.51e-06 | 4 | 23 | 2 | 22100894 | |
| Pubmed | 3.31e-06 | 157 | 23 | 4 | 30186101 | ||
| Pubmed | Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. | 4.18e-06 | 5 | 23 | 2 | 11564735 | |
| Pubmed | Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway. | 4.18e-06 | 5 | 23 | 2 | 21475249 | |
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 11912212 | ||
| Pubmed | 4.18e-06 | 5 | 23 | 2 | 14985122 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 11404076 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 26859354 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 11443112 | ||
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 19838210 | ||
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 6.26e-06 | 6 | 23 | 2 | 17021013 | |
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 37166352 | ||
| Pubmed | 8.77e-06 | 7 | 23 | 2 | 19556342 | ||
| Pubmed | 1.07e-05 | 65 | 23 | 3 | 22496869 | ||
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 21802298 | ||
| Pubmed | Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. | 1.17e-05 | 8 | 23 | 2 | 17158926 | |
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 20935208 | ||
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 17178841 | ||
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 17475621 | ||
| Pubmed | 1.17e-05 | 8 | 23 | 2 | 10823961 | ||
| Pubmed | Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone. | 1.50e-05 | 9 | 23 | 2 | 23640055 | |
| Pubmed | 1.50e-05 | 9 | 23 | 2 | 12370315 | ||
| Pubmed | 1.50e-05 | 9 | 23 | 2 | 24821727 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.55e-05 | 857 | 23 | 6 | 25609649 | |
| Pubmed | 1.86e-05 | 78 | 23 | 3 | 28611094 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 1.88e-05 | 10 | 23 | 2 | 30595551 | |
| Pubmed | 1.88e-05 | 10 | 23 | 2 | 12738788 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 1.88e-05 | 10 | 23 | 2 | 23746844 | |
| Pubmed | 2.29e-05 | 11 | 23 | 2 | 15546612 | ||
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 2.29e-05 | 11 | 23 | 2 | 15681609 | |
| Pubmed | Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects. | 2.29e-05 | 11 | 23 | 2 | 24051374 | |
| Pubmed | Activator-Mediator binding regulates Mediator-cofactor interactions. | 2.29e-05 | 11 | 23 | 2 | 20534441 | |
| Pubmed | 2.75e-05 | 12 | 23 | 2 | 11158331 | ||
| Pubmed | 2.75e-05 | 12 | 23 | 2 | 12189208 | ||
| Pubmed | 3.25e-05 | 13 | 23 | 2 | 15494311 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 3.25e-05 | 13 | 23 | 2 | 17761849 | |
| Pubmed | 3.25e-05 | 13 | 23 | 2 | 22936669 | ||
| Pubmed | 3.79e-05 | 14 | 23 | 2 | 12482968 | ||
| Pubmed | 3.99e-05 | 1014 | 23 | 6 | 32416067 | ||
| Pubmed | 4.16e-05 | 608 | 23 | 5 | 16713569 | ||
| Pubmed | 4.37e-05 | 15 | 23 | 2 | 9267036 | ||
| Pubmed | 4.37e-05 | 15 | 23 | 2 | 17925232 | ||
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 23870121 | ||
| Pubmed | 4.99e-05 | 16 | 23 | 2 | 24368734 | ||
| Pubmed | 5.66e-05 | 17 | 23 | 2 | 26180087 | ||
| Pubmed | 5.66e-05 | 17 | 23 | 2 | 19183483 | ||
| Pubmed | 5.66e-05 | 17 | 23 | 2 | 28291835 | ||
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 6.36e-05 | 18 | 23 | 2 | 17500065 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 6.44e-05 | 1105 | 23 | 6 | 35748872 | |
| Pubmed | 6.80e-05 | 1116 | 23 | 6 | 31753913 | ||
| Pubmed | 7.89e-05 | 20 | 23 | 2 | 21750544 | ||
| Pubmed | FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. | 7.89e-05 | 20 | 23 | 2 | 32350066 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 7.89e-05 | 20 | 23 | 2 | 29785026 | |
| Pubmed | 7.89e-05 | 20 | 23 | 2 | 19047629 | ||
| Pubmed | 7.89e-05 | 20 | 23 | 2 | 33431871 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 8.37e-05 | 358 | 23 | 4 | 32460013 | |
| Pubmed | Cripto is required for mesoderm and endoderm cell allocation during mouse gastrulation. | 8.72e-05 | 21 | 23 | 2 | 23747598 | |
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 27894818 | ||
| Pubmed | 9.59e-05 | 22 | 23 | 2 | 16751104 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 9.59e-05 | 22 | 23 | 2 | 26886794 | |
| Pubmed | 9.59e-05 | 22 | 23 | 2 | 24453338 | ||
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 1.05e-04 | 23 | 23 | 2 | 10235267 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.30e-04 | 774 | 23 | 5 | 15302935 | |
| Pubmed | The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs. | 1.35e-04 | 26 | 23 | 2 | 24391519 | |
| Pubmed | 1.45e-04 | 27 | 23 | 2 | 18838386 | ||
| Pubmed | Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons. | 1.45e-04 | 27 | 23 | 2 | 24496616 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.53e-04 | 1294 | 23 | 6 | 30804502 | |
| Pubmed | 1.56e-04 | 28 | 23 | 2 | 29365100 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 1.56e-04 | 28 | 23 | 2 | 31600191 | |
| Pubmed | 1.56e-04 | 28 | 23 | 2 | 24880616 | ||
| Pubmed | 1.56e-04 | 28 | 23 | 2 | 19114550 | ||
| Pubmed | 1.68e-04 | 29 | 23 | 2 | 26620267 | ||
| Pubmed | SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. | 1.68e-04 | 29 | 23 | 2 | 17928865 | |
| Interaction | FEV interactions | 2.62e-11 | 203 | 22 | 8 | int:FEV | |
| Interaction | TLE3 interactions | 1.00e-10 | 376 | 22 | 9 | int:TLE3 | |
| Interaction | CRX interactions | 1.57e-10 | 254 | 22 | 8 | int:CRX | |
| Interaction | NUP35 interactions | 2.90e-10 | 424 | 22 | 9 | int:NUP35 | |
| Interaction | EGR2 interactions | 4.29e-10 | 171 | 22 | 7 | int:EGR2 | |
| Interaction | MED23 interactions | 9.29e-09 | 266 | 22 | 7 | int:MED23 | |
| Interaction | GSC interactions | 3.32e-08 | 87 | 22 | 5 | int:GSC | |
| Interaction | SOX17 interactions | 5.17e-08 | 95 | 22 | 5 | int:SOX17 | |
| Interaction | GATA2 interactions | 5.62e-08 | 199 | 22 | 6 | int:GATA2 | |
| Interaction | SOX9 interactions | 5.74e-08 | 97 | 22 | 5 | int:SOX9 | |
| Interaction | PAX6 interactions | 8.30e-08 | 366 | 22 | 7 | int:PAX6 | |
| Interaction | TBR1 interactions | 1.24e-07 | 113 | 22 | 5 | int:TBR1 | |
| Interaction | TBXT interactions | 1.41e-07 | 116 | 22 | 5 | int:TBXT | |
| Interaction | EYA4 interactions | 1.83e-07 | 243 | 22 | 6 | int:EYA4 | |
| Interaction | PAX9 interactions | 2.49e-07 | 130 | 22 | 5 | int:PAX9 | |
| Interaction | HNF4A interactions | 3.80e-07 | 275 | 22 | 6 | int:HNF4A | |
| Interaction | NCOA6 interactions | 4.29e-07 | 145 | 22 | 5 | int:NCOA6 | |
| Interaction | AR interactions | 4.55e-07 | 992 | 22 | 9 | int:AR | |
| Interaction | TLX3 interactions | 5.29e-07 | 291 | 22 | 6 | int:TLX3 | |
| Interaction | SP7 interactions | 6.83e-07 | 304 | 22 | 6 | int:SP7 | |
| Interaction | FOS interactions | 7.95e-07 | 312 | 22 | 6 | int:FOS | |
| Interaction | GCM1 interactions | 8.28e-07 | 68 | 22 | 4 | int:GCM1 | |
| Interaction | TEAD1 interactions | 1.12e-06 | 176 | 22 | 5 | int:TEAD1 | |
| Interaction | ALG13 interactions | 1.36e-06 | 183 | 22 | 5 | int:ALG13 | |
| Interaction | LHX3 interactions | 1.43e-06 | 185 | 22 | 5 | int:LHX3 | |
| Interaction | NFIA interactions | 1.55e-06 | 188 | 22 | 5 | int:NFIA | |
| Interaction | HNF1B interactions | 1.63e-06 | 190 | 22 | 5 | int:HNF1B | |
| Interaction | SOX7 interactions | 1.76e-06 | 82 | 22 | 4 | int:SOX7 | |
| Interaction | KLF5 interactions | 1.86e-06 | 195 | 22 | 5 | int:KLF5 | |
| Interaction | IRF4 interactions | 2.03e-06 | 85 | 22 | 4 | int:IRF4 | |
| Interaction | SOX10 interactions | 2.79e-06 | 92 | 22 | 4 | int:SOX10 | |
| Interaction | CEBPA interactions | 3.04e-06 | 1245 | 22 | 9 | int:CEBPA | |
| Interaction | ERG interactions | 3.58e-06 | 223 | 22 | 5 | int:ERG | |
| Interaction | NFIX interactions | 3.91e-06 | 227 | 22 | 5 | int:NFIX | |
| Interaction | KLF3 interactions | 3.99e-06 | 228 | 22 | 5 | int:KLF3 | |
| Interaction | LHX1 interactions | 4.39e-06 | 103 | 22 | 4 | int:LHX1 | |
| Interaction | FOXP3 interactions | 5.23e-06 | 432 | 22 | 6 | int:FOXP3 | |
| Interaction | NR1H4 interactions | 5.49e-06 | 32 | 22 | 3 | int:NR1H4 | |
| Interaction | EN1 interactions | 5.70e-06 | 110 | 22 | 4 | int:EN1 | |
| Interaction | PAX8 interactions | 5.91e-06 | 111 | 22 | 4 | int:PAX8 | |
| Interaction | ASF1A interactions | 6.13e-06 | 249 | 22 | 5 | int:ASF1A | |
| Interaction | PAX7 interactions | 9.17e-06 | 124 | 22 | 4 | int:PAX7 | |
| Interaction | RELA interactions | 1.01e-05 | 485 | 22 | 6 | int:RELA | |
| Interaction | YAP1 interactions | 1.19e-05 | 1095 | 22 | 8 | int:YAP1 | |
| Interaction | KLF15 interactions | 1.28e-05 | 290 | 22 | 5 | int:KLF15 | |
| Interaction | HCFC1 interactions | 1.35e-05 | 293 | 22 | 5 | int:HCFC1 | |
| Interaction | SOX15 interactions | 1.52e-05 | 141 | 22 | 4 | int:SOX15 | |
| Interaction | PPARG interactions | 1.69e-05 | 307 | 22 | 5 | int:PPARG | |
| Interaction | ELF5 interactions | 1.79e-05 | 147 | 22 | 4 | int:ELF5 | |
| Interaction | NR1I2 interactions | 1.89e-05 | 48 | 22 | 3 | int:NR1I2 | |
| Interaction | KLF8 interactions | 2.36e-05 | 329 | 22 | 5 | int:KLF8 | |
| Interaction | LHX4 interactions | 2.89e-05 | 166 | 22 | 4 | int:LHX4 | |
| Interaction | SETD1A interactions | 3.18e-05 | 170 | 22 | 4 | int:SETD1A | |
| Interaction | H3C1 interactions | 3.30e-05 | 901 | 22 | 7 | int:H3C1 | |
| Interaction | TLX1 interactions | 3.56e-05 | 175 | 22 | 4 | int:TLX1 | |
| Interaction | GATA3 interactions | 4.61e-05 | 187 | 22 | 4 | int:GATA3 | |
| Interaction | MYOD1 interactions | 5.32e-05 | 194 | 22 | 4 | int:MYOD1 | |
| Interaction | NR3C1 interactions | 5.42e-05 | 974 | 22 | 7 | int:NR3C1 | |
| Interaction | ETV4 interactions | 5.65e-05 | 69 | 22 | 3 | int:ETV4 | |
| Interaction | CTBP1 interactions | 6.43e-05 | 406 | 22 | 5 | int:CTBP1 | |
| Interaction | MAML1 interactions | 6.68e-05 | 73 | 22 | 3 | int:MAML1 | |
| Interaction | MED1 interactions | 6.71e-05 | 206 | 22 | 4 | int:MED1 | |
| Interaction | WWTR1 interactions | 7.71e-05 | 422 | 22 | 5 | int:WWTR1 | |
| Interaction | SOX2 interactions | 7.87e-05 | 1422 | 22 | 8 | int:SOX2 | |
| Interaction | ASCL2 interactions | 8.81e-05 | 13 | 22 | 2 | int:ASCL2 | |
| Interaction | PAX2 interactions | 1.05e-04 | 85 | 22 | 3 | int:PAX2 | |
| Interaction | SMAD1 interactions | 1.27e-04 | 243 | 22 | 4 | int:SMAD1 | |
| Interaction | PPARA interactions | 1.33e-04 | 92 | 22 | 3 | int:PPARA | |
| Interaction | FOXI1 interactions | 1.33e-04 | 92 | 22 | 3 | int:FOXI1 | |
| Interaction | HCFC2 interactions | 1.33e-04 | 92 | 22 | 3 | int:HCFC2 | |
| Interaction | RBPJ interactions | 1.51e-04 | 254 | 22 | 4 | int:RBPJ | |
| Interaction | MAML2 interactions | 1.53e-04 | 17 | 22 | 2 | int:MAML2 | |
| Interaction | NCOR2 interactions | 1.75e-04 | 264 | 22 | 4 | int:NCOR2 | |
| Interaction | MAML3 interactions | 2.14e-04 | 20 | 22 | 2 | int:MAML3 | |
| Interaction | THRA interactions | 2.32e-04 | 111 | 22 | 3 | int:THRA | |
| Interaction | ELF4 interactions | 2.58e-04 | 115 | 22 | 3 | int:ELF4 | |
| Interaction | UTY interactions | 2.84e-04 | 23 | 22 | 2 | int:UTY | |
| Interaction | B4GALT2 interactions | 2.85e-04 | 119 | 22 | 3 | int:B4GALT2 | |
| Interaction | EYA2 interactions | 2.99e-04 | 121 | 22 | 3 | int:EYA2 | |
| Interaction | ETS1 interactions | 2.99e-04 | 121 | 22 | 3 | int:ETS1 | |
| Interaction | NR6A1 interactions | 3.09e-04 | 24 | 22 | 2 | int:NR6A1 | |
| Interaction | NFKB1 interactions | 3.11e-04 | 307 | 22 | 4 | int:NFKB1 | |
| Interaction | VDR interactions | 3.45e-04 | 127 | 22 | 3 | int:VDR | |
| Interaction | SMG7 interactions | 3.60e-04 | 319 | 22 | 4 | int:SMG7 | |
| Interaction | STAT5A interactions | 3.78e-04 | 131 | 22 | 3 | int:STAT5A | |
| Interaction | MED15 interactions | 3.78e-04 | 131 | 22 | 3 | int:MED15 | |
| Interaction | RUNX1 interactions | 3.82e-04 | 324 | 22 | 4 | int:RUNX1 | |
| Interaction | CXXC1 interactions | 3.86e-04 | 132 | 22 | 3 | int:CXXC1 | |
| Interaction | MAFA interactions | 3.93e-04 | 27 | 22 | 2 | int:MAFA | |
| Interaction | CREBBP interactions | 3.95e-04 | 599 | 22 | 5 | int:CREBBP | |
| Interaction | CARMIL2 interactions | 4.23e-04 | 28 | 22 | 2 | int:CARMIL2 | |
| Interaction | NR2F2 interactions | 4.49e-04 | 139 | 22 | 3 | int:NR2F2 | |
| Interaction | SRF interactions | 4.49e-04 | 139 | 22 | 3 | int:SRF | |
| Interaction | TLX2 interactions | 4.78e-04 | 142 | 22 | 3 | int:TLX2 | |
| Interaction | NFIB interactions | 4.78e-04 | 142 | 22 | 3 | int:NFIB | |
| Interaction | NUP43 interactions | 4.80e-04 | 625 | 22 | 5 | int:NUP43 | |
| Interaction | ELP3 interactions | 5.50e-04 | 149 | 22 | 3 | int:ELP3 | |
| Interaction | RTF1 interactions | 5.61e-04 | 150 | 22 | 3 | int:RTF1 | |
| Interaction | PAXIP1 interactions | 5.62e-04 | 359 | 22 | 4 | int:PAXIP1 | |
| Interaction | ETV5 interactions | 5.88e-04 | 33 | 22 | 2 | int:ETV5 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.79e-11 | 25 | 19 | 5 | 775 | |
| GeneFamily | Cyclins|Mediator complex | 5.42e-04 | 33 | 19 | 2 | 1061 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.40e-03 | 53 | 19 | 2 | 532 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 7.40e-07 | 200 | 23 | 5 | M9463 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 2.60e-05 | 200 | 23 | 4 | M9889 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 160 | 23 | 4 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 175 | 23 | 4 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-06 | 178 | 23 | 4 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-06 | 180 | 23 | 4 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 189 | 23 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.67e-06 | 192 | 23 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.73e-06 | 193 | 23 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-06 | 199 | 23 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-05 | 128 | 23 | 3 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 4.48e-05 | 135 | 23 | 3 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | 367C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.01e-05 | 157 | 23 | 3 | f511871e1a004c6e9af08ee325ab1bfc41807487 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-05 | 172 | 23 | 3 | 1565f38266891c3acf49778838de134c5dee5460 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 9.84e-05 | 176 | 23 | 3 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.00e-04 | 177 | 23 | 3 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 178 | 23 | 3 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 1.03e-04 | 179 | 23 | 3 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 182 | 23 | 3 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 182 | 23 | 3 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 182 | 23 | 3 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 183 | 23 | 3 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 184 | 23 | 3 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 23 | 3 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 23 | 3 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 186 | 23 | 3 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 186 | 23 | 3 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.16e-04 | 186 | 23 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 187 | 23 | 3 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 187 | 23 | 3 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 188 | 23 | 3 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 188 | 23 | 3 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 188 | 23 | 3 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 23 | 3 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 23 | 3 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 191 | 23 | 3 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 191 | 23 | 3 | f631749ef1f2270133664cf5eb4cf545a8482bd3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 192 | 23 | 3 | 562df5e87038c500dd3a003fe5374cb31946b145 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 1.29e-04 | 193 | 23 | 3 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 196 | 23 | 3 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-04 | 198 | 23 | 3 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 9.98e-07 | 194 | 22 | 5 | 1060_UP | |
| Drug | halofenate | 5.34e-06 | 4 | 22 | 2 | CID000033584 | |
| Disease | Adenoid Cystic Carcinoma | 1.05e-06 | 100 | 23 | 4 | C0010606 | |
| Disease | Squamous cell carcinoma of esophagus | 5.46e-05 | 95 | 23 | 3 | C0279626 | |
| Disease | autism spectrum disorder (is_implicated_in) | 6.93e-05 | 16 | 23 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | T-Cell Lymphoma | 6.93e-05 | 16 | 23 | 2 | C0079772 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 9.86e-05 | 19 | 23 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | age at first birth measurement | 1.09e-04 | 120 | 23 | 3 | EFO_0009101 | |
| Disease | puberty onset measurement | 1.24e-04 | 125 | 23 | 3 | EFO_0005677 | |
| Disease | Bladder Neoplasm | 1.73e-04 | 140 | 23 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.76e-04 | 141 | 23 | 3 | C0005684 | |
| Disease | Craniofacial Abnormalities | 2.38e-04 | 156 | 23 | 3 | C0376634 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.57e-04 | 195 | 23 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | Breast adenocarcinoma | 4.68e-04 | 41 | 23 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.68e-04 | 41 | 23 | 2 | C0496956 | |
| Disease | chronotype measurement | 5.07e-04 | 882 | 23 | 5 | EFO_0008328 | |
| Disease | neuroticism measurement | 5.82e-04 | 909 | 23 | 5 | EFO_0007660 | |
| Disease | Diffuse Large B-Cell Lymphoma | 8.42e-04 | 55 | 23 | 2 | C0079744 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.10e-03 | 63 | 23 | 2 | DOID:0050866 (is_marker_for) | |
| Disease | diet measurement | 1.11e-03 | 1049 | 23 | 5 | EFO_0008111 | |
| Disease | age at initiation of smoking | 1.21e-03 | 66 | 23 | 2 | EFO_0021784 | |
| Disease | breast carcinoma (is_marker_for) | 1.21e-03 | 66 | 23 | 2 | DOID:3459 (is_marker_for) | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 1.28e-03 | 68 | 23 | 2 | EFO_0007826, EFO_0007860 | |
| Disease | schizophrenia (is_implicated_in) | 1.68e-03 | 78 | 23 | 2 | DOID:5419 (is_implicated_in) | |
| Disease | irritability measurement | 1.86e-03 | 82 | 23 | 2 | EFO_0009594 | |
| Disease | feeling nervous measurement | 2.09e-03 | 87 | 23 | 2 | EFO_0009597 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTQPQVQAKNQQNQQ | 481 | Q09472 | |
| QKQLQQQQQQPPSQL | 281 | Q9Y2D5 | |
| QQPQQVQMQVQPQQS | 1031 | Q68CP9 | |
| QPQQKDPQQPAQQQQ | 301 | O75909 | |
| PQTQQEQQIQVQQPQ | 86 | Q2TAL8 | |
| QQQQQQQQQQPMPRS | 501 | Q9Y618 | |
| QPQNLQMQQQNLQPA | 2386 | P46531 | |
| RLLQMQQPQQPQPQQ | 2061 | Q86YW9 | |
| QNNPPRQQQNQNKPL | 391 | Q6NUN7 | |
| NPLMPYIQQQQQQQQ | 626 | Q96JK9 | |
| PQQMQQILQQQVLSP | 101 | O15409 | |
| QQQQQQQALQAQPPI | 256 | Q96RN5 | |
| NQQQNNLPEQPNQIP | 1381 | P42694 | |
| PQPNQVVQQQSQLNQ | 1396 | P42694 | |
| VVQQQSQLNQQPQQP | 1401 | P42694 | |
| FNPNQNPMANQEQQN | 1291 | O94916 | |
| QMNPANFPQLQQQQQ | 251 | Q14686 | |
| KTQPQPQQQQRQQQQ | 11 | Q8NE35 | |
| QQQQQQQAALPQMPL | 256 | Q6PJG2 | |
| NNNQMFPPNQQQQQL | 971 | Q9P267 | |
| PNANQNLTQNLMQNL | 551 | Q96MM7 | |
| QPQSQQQQPQHIQLQ | 746 | Q3ZLR7 | |
| QQQQQQLSQFTPQQP | 636 | Q8NEM7 | |
| QQQQQQQPQSPQRLL | 16 | Q5VX71 | |
| QQQQEQLQQQQLQPP | 296 | P0CG23 | |
| AQPMGSLQQLQQQQQ | 3891 | O14686 | |
| PQQQQQLQALLMQRQ | 4216 | O14686 |